All-cause and in-hospital mortality after aspirin use in patients hospitalized with COVID-19: a systematic review and meta-analysis.
Nischit BaralJoshua D MitchellPramod K SavarapuMaxwell AkanbiBandana AcharyaSoumya KambalapalliAmith Reddy SeriKrishna P BashyalArvind KunadiNiranjan OjhaAnnabelle Santos VolgmanTripti GuptaTimir K PaulPublished in: Biology methods & protocols (2022)
Our study shows that aspirin decreases in-hospital mortality in patients hospitalized with COVID-19. Further studies are needed to assess which COVID-19 patient populations benefit most, such as patients on aspirin for primary versus secondary prevention of atherosclerotic disease. In addition, significant bleeding also needs to be considered when assessing the risk-benefit of aspirin use.